Your Health, We Care
Most common (>20%) adverse reactions, including laboratory abnormalities were leukopenia, lymphopenia, thrombocytopenia, diarrhea, anemia, rash, musculoskeletal pain, nail toxicity, neutropenia, dry skin, stomatitis, fatigue, and cough.
from FDA，2022.10
Lucius Pharmaceuticals Osimertinib is a targeted therapy used to treat non-small···【more】
Release date：2026-03-06Recommended：19
Tell your healthcare provider about all the medicines you take, including prescr···【more】
Release date：2026-02-11Recommended：35
Medicines are sometimes used for purposes other than those listed in the patient···【more】
Release date：2026-02-11Recommended：46
Osimertinib is used for the prevention of recurrence in patients with non-small ···【more】
Release date：2026-02-11Recommended：37
The development of cancer treatment drugs has brought hope to patients, but it h···【more】
Release date：2025-03-10Recommended：195
Osimertinib is a targeted therapy that plays an important role in the treatment ···【more】
Release date：2025-03-07Recommended：237
Osimertinib is an important drug for the treatment of non-small cell lung cancer···【more】
Release date：2025-03-07Recommended：220
